News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
QIAGEN receives FDA clearance of QIAstat-Dx meningitis/encephalitis panel to support emergency diagnostics
Monday, November 04, 2024QIAGEN announced that the US Food and Drug Administration FDA has cleared the QIAstatDx MeningitisEncephalitis Panel for clinical use This marks the fourth QIAstatDx syndromic test to receive US regulatory clearance in
PURE Bioscience Announces Distribution Agreement with Quip Laboratories
Saturday, November 02, 2024PURE Bioscience Inc creator of the patented nontoxic silver dihydrogen citrate SDC antimicrobial and Quip Laboratories Inc have entered into a multiyear distribution agreement for the purchase and selling of SDC products under special terms and condi...
Hyperfine Announces Alzheimer’s Research with Promising Swoop® System Data and Advanced Image Quality
Friday, November 01, 2024Hyperfine Inc the groundbreaking health technology company that has redefined brain imaging with the first FDAcleared portable magnetic resonance MR brain imaging systemthe Swoop systemtoday announced the presentation of additional research data and...
Spur Therapeutics Publishes Preclinical Proof-of-Concept Data for SBT101, its Gene Therapy Candidate in Adrenomyeloneuropathy (AMN)
Friday, November 01, 2024Spur Therapeutics today announced the publication of preclinical proofofconcept data for SBT its potential firstinclass gene therapy program for the treatment of adrenomyeloneuropathy AMN in Molecular Therapy Methods Clinical Development AMN is a ra...
ViaNautis Bio Signs Strategic Collaboration Agreement with Lilly to leverage its polyNaut® platform to develop novel products delivering genetic medicines
Tuesday, October 29, 2024ViaNautis Bio a groundbreaking biotechnology company at the forefront of delivering targeted genetic nanomedicines today announces a collaboration with Eli Lilly and Company Lilly Under the terms of the agreement ViaNautis will receive an initial upf...
QIAGEN receives FDA clearance for QIAstat-Dx mini panel to improve precision in outpatient respiratory treatment
Tuesday, October 29, 2024QIAGEN announced that the US Food and Drug Administration FDA has cleared the QIAstatDx Respiratory Panel Mini test for clinical use It is the third test to receive FDA clearance for use with QIAstatDx systems in The QIAstatDx Respiratory Panel Mini...
Introducing iQue®'s 2nd Edition High-Throughput Cytometry Handbook: Fast. Simple. Discover the Future of Cell Analysis!
Monday, October 28, 2024The life science group Sartorius has published its second edition HighThroughput Screening HTS by Cytometry handbook This handbook is designed to empower both new and seasoned flow cytometry users who are curious about the unique capabilities of HTS...
Bayer and Dewpoint Therapeutics sign Licensing Agreement for Heart Disease Program
Friday, October 25, 2024Bayer has entered into an exclusive licensing agreement with Dewpoint Therapeutics Inc for a heart disease program to treat dilated cardiomyopathy DCM patients who are characterized through carrying specific mutations This is the first option exercis...
Lyell Immunopharma to Acquire ImmPACT Bio and Prioritizes its Pipeline to Focus on Next-Generation CAR T-cell Therapies
Friday, October 25, 2024Lyell Immunopharma Inc announced today that it has entered into a definitive agreement to acquire ImmPACT Bio USA Inc ImmPACT a privatelyowned clinicalstage biotechnology company ImmPACTs lead program IMPT is a CDtargeting chimeric antigen receptor C...
PolTREG launches Phase 2 cell therapy trial in children with presymptomatic diabetes
Thursday, October 24, 2024PolTREG SA a clinicalstage biotechnology company developing cellular therapies for a wide range of autoimmune diseases has launched a placebocontrolled Phase clinical trial with PTG Treg cell therapy in presymptomatic type diabetes TD patients after...
